Gilead Sciences reported $2.26B in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Agios Pharmaceuticals AGIO:US $ -91222000 5K
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
ALKERMES ALKS:US 4.42M 20.85M
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Amgen AMGN:US $ 2333M 204M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
Biogen BIIB:US $ 1030.1M 12.3M
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Bluebird Bio BLUE:US $ -240791000 9.95M
Bristol Myers Squibb BMY:US $ 2967M 411M
Coherus Biosciences CHRS:US $ -24164000 143.2M
Eli Lilly And LLY:US $ 1428.4M 237.8M
Gilead Sciences GILD:US $ 2262M 639M
GlaxoSmithKline GSK:LN 1.96B 281M
Glaxosmithkline GSK:US 1.96B 281M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
Johnson & Johnson JNJ:US $ 6901M 94M
Merk MRK:US $ 3930M 332M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Novartis NOVN:VX 3.4B 415M
Pfizer PFE:US $ 6662M 905M
Ptc Therapeutics PTCT:US $ -98493000 345K
Puma Biotechnology PBYI:US $ -16633000 36.78M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sangamo Biosciences SGMO:US $ -48700000 2.4M
Sarepta Therapeutics SRPT:US $ -167574000 25.71M
Teva Pharmaceutical Industries TEVA:US 829M 35M
United Therapeutics UTHR:US $ 222.2M 263.9M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
YTE INCY:US $ 155.31M 40.5M